ANIX
Anixa Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.07
+0.66%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-69.6%
Return on equity
-67.8%
Return on assets
-72.8%
Return on invested capital
0.00x
Asset turnover
-$7.1M
Cash from operations
$0.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026